News | January 03, 2026
Cupid reports record Q3, eyes GCC expansion with Saudi FMCG facility
Cupid is strengthening its footprint in the GCC region, focusing on supply responsiveness and market proximity
Cupid is strengthening its footprint in the GCC region, focusing on supply responsiveness and market proximity
The company announced that it has been granted patent covering “Substituted Ethylamine Fused Heterocyclic Mescaline Derivatives.”
The study will run across 18 sites and enroll roughly 200 patients over 24 months
The Toumai platform, currently the only robotic system with US FDA Study Approval for telesurgery, enabled real-time surgical control with no compromise to patient safety
The plant is expected to enhance regional supply capabilities
TMS offers new hope to patients suffering from stroke, migraine, neuropathic pain, depression, and other disorders
NGD Infection Prevention was formed to scale the delivery of sequence-based transmission detection
For 2026 onwards, CPHI and PMEC India are evolving into two distinct, specialized shows
The primary goal of the collaboration is joint research into trending and next-generation molecules
Lupin has bolstered its diabetes and obesity portfolios by securing an agreement for Bofanglutide, a GLP-1 receptor agonist developed by Gan & Lee Pharmaceuticals
Subscribe To Our Newsletter & Stay Updated
